University of Kansas Cancer Center-Westwood

Westwood, Kansas 66205

4 studies enrolling now · 11 studies all time

What they study most

Advanced Melanoma, Advanced Non Small Cell Lung Cancer, Advanced Urothelial Carcinoma, Breast Cancer, Chronic Graft-Versus-Host Disease (cGVHD), Gastrointestinal Cancer, MF, Myelofibrosis, Pancreas Cancer, Post-ET Myelofibrosis, Post-PV MF, Primary Myelofibrosis

Studies at this site

• Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer — Recruiting now
• Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM) — Recruiting now
• A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD) — Recruiting now
• Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib — Recruiting now
• A Trial to Learn if the Combination of Fianlimab, Cemiplimab, and Chemotherapy is Safe and Works Better Than the Combination of Cemiplimab and Chemotherapy in Adult Patients With Non-Small Cell Lung Cancer That Can be Treated With Surgery — Running, not enrolling
• Letrozole Plus Ribociclib or Placebo as Neo-adjuvant Therapy in ER-positive, HER2-negative Early Breast Cancer — Running, not enrolling
• Cisplatin Plus Romidepsin & Nivolumab in Locally Recurrent or Metastatic Triple Negative Breast Cancer (TNBC) — Running, not enrolling
• A Study to Evaluate Safety, Efficacy of FF-10832 in Combo With Pembrolizumab in Urothelial & Non-small Cell Lung Cancer — Running, not enrolling
• Tg01 Vaccine / Qs-21 Stimulon™ With Or Without Balstilimab As Maintenance Therapy Following Adjuvant Chemotherapy In Patients With Resected Pancreatic Cancer — Running, not enrolling
• Capecitabine in Metastatic Breast and GI Cancers — Status unconfirmed
• Neoadjuvant Study of Two Platinum Regimens in Triple Negative Breast Cancer — Completed